CN201409998Y - Penis thickening gasket with mechanical compliance - Google Patents
Penis thickening gasket with mechanical compliance Download PDFInfo
- Publication number
- CN201409998Y CN201409998Y CN2009200516679U CN200920051667U CN201409998Y CN 201409998 Y CN201409998 Y CN 201409998Y CN 2009200516679 U CN2009200516679 U CN 2009200516679U CN 200920051667 U CN200920051667 U CN 200920051667U CN 201409998 Y CN201409998 Y CN 201409998Y
- Authority
- CN
- China
- Prior art keywords
- penis
- gasket
- thickening
- thick
- joint
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003899 penis Anatomy 0.000 title claims abstract description 41
- 230000008719 thickening Effects 0.000 title claims abstract description 15
- 238000007920 subcutaneous administration Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000012620 biological material Substances 0.000 abstract description 4
- 239000012528 membrane Substances 0.000 abstract description 4
- 206010062575 Muscle contracture Diseases 0.000 abstract description 2
- 208000006111 contracture Diseases 0.000 abstract description 2
- 238000004904 shortening Methods 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920002379 silicone rubber Polymers 0.000 description 5
- 239000004945 silicone rubber Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 150000002118 epoxides Chemical class 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- -1 OP-10 Chemical compound 0.000 description 3
- 239000012042 active reagent Substances 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000012412 chemical coupling Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 238000005987 sulfurization reaction Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JPSKCQCQZUGWNM-UHFFFAOYSA-N 2,7-Oxepanedione Chemical compound O=C1CCCCC(=O)O1 JPSKCQCQZUGWNM-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- HZWXJJCSDBQVLF-UHFFFAOYSA-N acetoxysulfonic acid Chemical compound CC(=O)OS(O)(=O)=O HZWXJJCSDBQVLF-UHFFFAOYSA-N 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Images
Landscapes
- Prostheses (AREA)
Abstract
The utility model discloses a structure of a penis thickening gasket with mechanical compliance and a preparation method; the penis thickening gasket is composed of a membrane with thick sections andthin sections which are arranged at interval; the penis wrapped up subcutaneously forms a ring-joint *-shaped non-enclosed tube. The thick ring is used for thickening the penis, and the thin ring is used for shortening and extending, and the * shape can swell and shrink; in the way, the gasket can extend, swell and shrink compliantly according to physiological change of penis erection and bating.The gasket is mainly made of natural biomaterial material which has good biomaterial compatibility and high stability, after the gasket is embedded, the compatibility is good without causing exclusivereaction and generating fiber kystis contracture, and the gasket can induce the tissue of a patient to grow in, so as to realize the thickening of autologous tissue.
Description
Technical field
This utility model relate to a kind of by surgical operation at subcutaneous parcel penis, make penis increase thick implantation class pad, belong to III class medical apparatus and instruments.
Background technology
The microcaulia that obesity causes when congenital or disease or child often makes that adult male is worried to can't bear, even influence marriage situation and family relation, the normal male less than normal of some penises, and also serious hope can become thicker with penis.Require the elongated chap person of penis to cosmetic surgery hospital, there is no lack of such people.Penis is elongated, and prior art solves, and with the penis chap, suitable material and method is not arranged so far.This utility model provides a kind of good biocompatibility, longitudinal tensile strain and laterally swelling simultaneously in the time of can be with erection is done when penis is softening vertically to shorten and the horizontal little pad of receipts, is used to implant subcutaneous parcel penis, penis is increased thick the time, can suddenly make compliance with the receipts of penis and change.
The utility model content
The utility model discloses a kind of structure and preparation method of penis thickening pad with mechanical adaptability.
A kind of penis thickening pad with mechanical adaptability of the present utility model, it is characterized in that it be thick by a joint, a joint is thin, thickness is alternate and the diaphragm that is connected as a single entity constitutes.Thick saving effectively to increase thick penis, thin saving with compression and elongation is similar to those link shape telescoping tubes.But this pad is an inc longitudinal cut that leaves
Shape pipe shape can open and draw in, so just can and softeningly magnify and receives carefully as compliance with the erection of penis.The flexible structural design of this two dimension cooperates suitable implant surgery again, can do the elongation of compliance and swell with the erection of penis after can making penis increase thick pad to implant, do the compliance shortening and receive thin with the softening of penis, can satisfy the biomechanics requirement of penis physiological change, can not limit the erection of penis and softening, can not produce sense of discomfort.
Describedly increase thick pad by thick joint, the alternate penis that constitutes of thin joint, the thickness of thick joint is 2mm~10mm, and width is 3mm~15mm; The thickness of Bao Jie is 0.1mm~3.0mm, and width is 3mm~15mm.The width of whole pad is 40mm~130mm, length (girth) 60mm~150mm, and its length and width can be cut out according to actual needs.
The preparation material of this penis thickening pad with mechanical adaptability has two kinds: the one, and with the synthetic material manufacturing of good biocompatibility, the 2nd, be the manufacturing of raw material natural biologic material in order to animal tissue.
Prepare the method for penis thickening pad with mechanical adaptability with synthetic material, identical with the machining manufacture of general plastics or rubber.By said structure requirement design corresponding mould, make with injection molding method or compression molding method or dip forming method, available once moulding method makes the alternate diaphragm of thickness, also can make film and thicker slip earlier, again slip is fixed on the film at a certain distance, even is pressed in the middle of two films the sheet bar is sticking with two thin film.At this moment, the sheet bar can be made sponge or varicosity, or even hollow, notes silicon gel.Key is that material is wanted excellent biological compatibility, does not cause serious fibrous tissue encapsulation and kystis contracture after the implantation, does not cause the sense of discomfort that foreign body stimulates, and enough compliances will be arranged, and alternative material has silicone rubber, polyurethane and expanded PTFE.
When preparing penis thickening pad with mechanical adaptability with natural biologic material, earlier modify and handle the biomembrane that makes stable height, good biocompatibility, can induce autologous tissue to grow into by crosslinked fixing, multi-faceted antigen and the surface activity removed with animal membrane tissue, simultaneously, with thicker tissues such as the tendon of animal, flap, blood vessel wall, slitting, same method is handled and is made stability height, good biocompatibility, the biological slip that the energy induced tissue is grown into.Biological slip is fixed on the biomembrane with a determining deviation by the said structure requirement, promptly gets the alternate diaphragm of thickness.Fixed method can be sewed up with suture.Be inc with this diaphragm with pipe shape mould shape in case of necessity
Shape pipe shape, method for shaping are processing such as pressurization, deep cooling, vacuum.
Here crosslinked described in biomembrane and the biological slip preparation method is meant that fixedly will to form the tropocollagen molecule of biomembrane and biological slip with cross-linking agent crosslinked, makes it stable.Used cross-linking agent has glutaraldehyde, carbodiimides, polyvinyl alcohol, epoxide etc.Preferably use the epoxide shown in the following formula:
Here R=C
nH
2n+1-or
N=0,1,2,3 ... 12.The ideal crosslinked collagen component that makes is highly stable.
Here the multi-faceted antigen that removes described in biomembrane and the biological slip preparation method is meant to comprise with taking off cell and eliminating the antigenic specific structure factor that causes with several different methods such as active reagent blocking antigen group and destruction antigen conformations.The described cell that takes off is meant with protease hydrolyzed or detergent destruction cell wall, and cell is removed.Used protease has pepsin, trypsin, and enzymolysis carries out under room temperature to 50 ℃.Detergent can be used TritonX X100 (Triton x100), Tris, and tween, surfactants such as OP-10, its principle is the fat-soluble group destruction cell wall with surfactant, makes its eluting that breaks.The active reagent blocking antigen of described usefulness epi-position is meant with the special antigen group of nucleopilic reagents such as anhydride, acyl chlorides, amide, epoxide sealing.The active reagent of described destruction antigen conformation is that a class strong hydrogen bonding forms agent, mainly is guanidine compound, example hydrochloric acid guanidine etc.
Here the modification of the surface activity described in biomembrane and biological slip preparation method processing is meant and can adheres in somatomedin and the cell activity component introducing goods, enables to induce host tissue to grow into, and gradually with implant assimilate into autologous tissue.Described active component is meant that a class contains the specific polypeptide of arginine~glycine~aspartyl dipeptide section and polylysine peptide section, as bad (16)-Gan-essence-Gan-Radix Asparagi-Si-dried meat-half Guang polypeptide, or the glycosaminoglycans complex.Described glycosaminoglycans is meant hyaluronic acid, chondroitin sulfate, keratan sulfate, sulphuric acid cortin, heparin, acetylsulfuric acid heparin etc.The mode of introducing can be adhesion, absorption, coating, chemical coupling etc.The coupling agent of chemical coupling can be used difunctional materials such as dicarboxylic anhydride, diacid chloride, diamides, di-epoxide.
The superiority that penis of the present utility model increases thick pad is that its biocompatibility and biomechanics compliance are good, all material is animal tissue's material of being made up of collagen, after my specific biochemical technology is handled, stability is high, good biocompatibility, do not cause rejection, can induce grown into wherein by main tissue, finally realize the thick effect of increasing of autologous tissue.Can the flexible construction features of two dimension (two-way), can and softeningly do elongation and increase compliance variation thick and that dwindle with the erection of penis.As long as operation is proper, can and softeningly not cause obstacle and sense of discomfort to the erection of penis, be ideal penis overstriking device.
Description of drawings
Fig. 1 is the structural representation that penis with mechanics compliance increases thick pad.
Fig. 2 is fixed to the not structural representation of the piped penis thickening pad with mechanical adaptability of closed circle in advance.
The specific embodiment
Embodiment one:
Get Cor Sus domestica bag and aorta, remove impurity, the vertical cutting of tremulous pulse, flatten, pericardium and arterial wall slip are put into taken off cell reactor and add trypsin solution (0.125g/ml), made enzyme digestion reaction 4~24 hours, take out, clean, put into crosslinked fixed reactor, add the epoxide solution shown in the following formula:
R=C
nH
2n+1-or
N=0,1,2,3 ... 12.Made cross-linking reaction 24~72 hours, and took out, clean, put into, add the trimethylacetic acid acid anhydride except that the antigen-reactive device
Make reaction 4~24 hours, take out, clean, the cleaning reaction device is put back to sample except that in the antigen-reactive device again simultaneously, the Tris buffer that adds guanidine hydrochloride, make reaction 12~36 hours, take out, clean, put into surface activity modification reaction device, add and rely (16)-Gan-essence-Gan-Radix Asparagi-Si-dried meat-half Guang polypeptide solution and coupling agent uncle adipic anhydride
Make reaction 8~48 hours, take out, clean.The rectangular sutured at a certain distance of tremulous pulse on the pericardium thin film, is made thick, thin alternate diaphragm.Diaphragm is configured as by pressurization, deep cooling, application of vacuum with mould
The inc pipe shape of shape promptly gets product of the present utility model.
Embodiment two:
Producing silicone rubber membrane and thickness with particular manufacturing craft by dip forming or doctor blading method, to satisfy the silicone sponge of said structure designing requirement rectangular, rectangular spacing by structural requirement is adhered on the silicone rubber membrane, flood last layer silicone rubber ultrathin membrane again, sulfuration, clean, prune, promptly get product of the present utility model.
Embodiment three:
By said structure requirement mfg. moulding die, make the alternate diaphragm of thickness with flexible best silicone rubber mold pressing or injection moulding one-shot forming, sulfuration is cleaned, and cuts out and promptly gets product of the present utility model.
Claims (3)
1, a kind of penis thickening pad with mechanical adaptability, it is characterized in that it is thick by a joint, a joint is thin, and thickness diaphragm alternate and that be connected as a single entity constitutes, it is subcutaneous that this diaphragm is wrapped in penis, but can form a link shape, scalable opening and closing, with the tubular body of vertical breach.
2, penis thickening pad with mechanical adaptability according to claim 1, the thickness that it is characterized in that described thick joint is 2mm~12mm, width is 3mm~15mm; The thickness of Bao Jie is 0.1~3.0mm, and width is 3mm~15mm, the width 40mm~130mm of whole pad, length 60~150mm.
3,, it is characterized in that it can make not closed circle tubular body according to the described penis thickening pad with mechanical adaptability of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009200516679U CN201409998Y (en) | 2009-02-25 | 2009-02-25 | Penis thickening gasket with mechanical compliance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009200516679U CN201409998Y (en) | 2009-02-25 | 2009-02-25 | Penis thickening gasket with mechanical compliance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201409998Y true CN201409998Y (en) | 2010-02-24 |
Family
ID=41711890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009200516679U Expired - Lifetime CN201409998Y (en) | 2009-02-25 | 2009-02-25 | Penis thickening gasket with mechanical compliance |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201409998Y (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101491466B (en) * | 2009-02-25 | 2011-09-07 | 广东冠昊生物科技股份有限公司 | Penis thickening pad with mechanics compliance |
-
2009
- 2009-02-25 CN CN2009200516679U patent/CN201409998Y/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101491466B (en) * | 2009-02-25 | 2011-09-07 | 广东冠昊生物科技股份有限公司 | Penis thickening pad with mechanics compliance |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11383426B2 (en) | Method of patterning a surface and articles comprising the same | |
| CN101395267B (en) | Production of engineered cells on polymeric membranes and their applications in bioengineering | |
| ES2323661T3 (en) | METHOD OF PREPARATION OF A VASCULAR PROTESIS. | |
| ES2385301T3 (en) | Myocardial cell sheets and processes to produce them | |
| CN101427947A (en) | Multifunctional female pelvic cavity biological sticking patch | |
| CN105664260A (en) | Method for preparing bone tissue engineering three-dimensional porous support based on graphene/silk fibroin | |
| CN101491466B (en) | Penis thickening pad with mechanics compliance | |
| CN201409998Y (en) | Penis thickening gasket with mechanical compliance | |
| CN101332316B (en) | Biotype nose bridge implantation body | |
| CN1986006A (en) | Biological nerve duct | |
| CN101371932A (en) | Biotype artificial jaw bone | |
| ES2742530T3 (en) | Artificial biomembrane that uses a cocoon and method to manufacture it | |
| CN113088452A (en) | Aorta organoid chip, preparation method, chip system and application | |
| CN105944141B (en) | Cervical biomimetic for transplantation and preparation method thereof | |
| AU2007268748A1 (en) | Method of culturing vascular smooth muscle cells, culture device and medical material obtained by the culture | |
| AU2017346791B2 (en) | Tuning adhesion at contacting device interfaces: geometric tools for minimizing surface fouling | |
| CN101433477B (en) | Biotype breast-hanging strip | |
| CN102068325A (en) | Compound anti-blocking herniorrhaphy patch and preparation method thereof | |
| CN107213510A (en) | A kind of preparation method of high intensity curvature collagem membrane | |
| CN101396292A (en) | One-piece urethra hanging strip | |
| CN1861018B (en) | Combination ear supporter | |
| CN202355479U (en) | Novel carbon fiber rhinoplastic prosthesis | |
| CN210903670U (en) | Tissue repair biomembrane skin patch | |
| Fell et al. | Bio-hybrid soft robotic bioreactors for mimicking multi-axial femoropopliteal artery mechanobiology | |
| CN206081142U (en) | Artifical tendon flange tool of bacterium cellulose membrane organizational projectization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20100224 |
|
| CX01 | Expiry of patent term |